Healthcare Professionals Investor Login Turkish
About Trustlife Labs Drug R&D Center News Contact
Trustlife

Patents

Small Molecule Treatment of Fatty Liver Disease and HCC - EPO

Liver CancerPatent

21.08.2024

Small Molecule Treatment of Fatty Liver Disease and HCC - EPO from TRUSTLIFE

Description:

The present disclosure relates to a pharmaceutical compound used for the treatment of fatty liver disease and hepatocellular carcinoma (HCC).

You may also be interested in

  • Visit of Minister of Health Prof. Dr. Kemal Memişoğlu to Trustlife
    Visits

    Visit of Minister of Health Prof. Dr. Kemal Memişoğlu to Trustlife

  • Multi-Target Neuroprotective Compound Exhibits EAAT2-Modulating and Alzheimer’s Pathology–Attenuating Effects in In Vitro and In Vivo Models
    Scientific Documents

    Multi-Target Neuroprotective Compound Exhibits EAAT2-Modulating and Alzheimer’s Pathology–Attenuating Effects in In Vitro and In Vivo Models

  • Clinical Application for the First National Alzheimer’s Drug – Trustlife Press Release – 20.02.2026
    Recent News

    Clinical Application for the First National Alzheimer’s Drug – Trustlife Press Release – 20.02.2026

Trustlife
About Trustlife Labs Drug R&D Center Contact